160 related articles for article (PubMed ID: 14744908)
1. Inhibition of choroidal neovascularization in rats by the urokinase-derived peptide A6.
Koh HJ; Bessho K; Cheng L; Bartsch DU; Jones TR; Bergeron-Lynn G; Freeman WR
Invest Ophthalmol Vis Sci; 2004 Feb; 45(2):635-40. PubMed ID: 14744908
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of choroidal neovascularization by a peptide inhibitor of the urokinase plasminogen activator and receptor system in a mouse model.
Das A; Boyd N; Jones TR; Talarico N; McGuire PG
Arch Ophthalmol; 2004 Dec; 122(12):1844-9. PubMed ID: 15596589
[TBL] [Abstract][Full Text] [Related]
3. [Inhibitory effect of RGDS peptide on experimental choroidal neovascularization in a rat model].
He H; Zhang H; Wang ZT; Zhao CM; Xiang N
Zhonghua Yan Ke Za Zhi; 2006 Sep; 42(9):825-31. PubMed ID: 17173745
[TBL] [Abstract][Full Text] [Related]
4. Effect of a novel octapeptide urokinase fragment, A6, on experimental choroidal neovascularization in the monkey.
Koh HJ; Freeman WR; Azen SP; Flaxel CJ; Labree LD; Cheng L; Wills M; Jones TR
Retina; 2006 Feb; 26(2):202-9. PubMed ID: 16467679
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization.
Murata T; He S; Hangai M; Ishibashi T; Xi XP; Kim S; Hsueh WA; Ryan SJ; Law RE; Hinton DR
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2309-17. PubMed ID: 10892878
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-β inhibition decreases diode laser-induced choroidal neovascularization development in rats: P17 and P144 peptides.
Recalde S; Zarranz-Ventura J; Fernández-Robredo P; García-Gómez PJ; Salinas-Alamán A; Borrás-Cuesta F; Dotor J; García-Layana A
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7090-7. PubMed ID: 21810978
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal human complement factor H in a rat model of laser-induced choroidal neovascularisation.
Kim SJ; Kim J; Lee J; Cho SY; Kang HJ; Kim KY; Jin DK
Br J Ophthalmol; 2013 Mar; 97(3):367-70. PubMed ID: 23258212
[TBL] [Abstract][Full Text] [Related]
8. Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.
Renno RZ; Terada Y; Haddadin MJ; Michaud NA; Gragoudas ES; Miller JW
Arch Ophthalmol; 2004 Jul; 122(7):1002-11. PubMed ID: 15249365
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of experimental choroidal neovascularization in rats by an alpha(v)-integrin antagonist.
Yasukawa T; Hoffmann S; Eichler W; Friedrichs U; Wang YS; Wiedemann P
Curr Eye Res; 2004 May; 28(5):359-66. PubMed ID: 15287373
[TBL] [Abstract][Full Text] [Related]
10. The urokinase/urokinase receptor system in retinal neovascularization: inhibition by A6 suggests a new therapeutic target.
McGuire PG; Jones TR; Talarico N; Warren E; Das A
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2736-42. PubMed ID: 12766081
[TBL] [Abstract][Full Text] [Related]
11. [Study on the experimental model of krypton laser-induced choroidal neovascularization in the rats].
Zhao SH; He SZ
Zhonghua Yan Ke Za Zhi; 2003 May; 39(5):298-302. PubMed ID: 12892608
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of bucillamine on laser-induced choroidal neovascularization in rats.
Hikichi T; Mori F; Sasaki M; Takamiya A; Nakamura M; Shishido N; Takeda M; Horikawa Y; Matsuoka H; Yoshida A
Curr Eye Res; 2002 Jan; 24(1):1-5. PubMed ID: 12187488
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects between intravitreal and periocular injections of adenoviral vectored pigment epithelium-derived factor on suppressing choroidal neovascularization in rats.
Yan H; Cui J; Wang Y; Yu Y
Ophthalmic Res; 2013; 49(2):81-9. PubMed ID: 23257710
[TBL] [Abstract][Full Text] [Related]
14. Intraocular properties of urokinase-derived antiangiogenic A6 peptide in rabbits.
Koh HJ; Cheng L; Bessho K; Jones TR; Davidson MC; Freeman WR
J Ocul Pharmacol Ther; 2004 Oct; 20(5):439-49. PubMed ID: 15650519
[TBL] [Abstract][Full Text] [Related]
15. Preventive versus treatment effect of AG3340, a potent matrix metalloproteinase inhibitor in a rat model of choroidal neovascularization.
El Bradey M; Cheng L; Bartsch DU; Appelt K; Rodanant N; Bergeron-Lynn G; Freeman WR
J Ocul Pharmacol Ther; 2004 Jun; 20(3):217-36. PubMed ID: 15279727
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody-mediated drug targeting to choroidal neovascularization in the rat.
Kamizuru H; Kimura H; Yasukawa T; Tabata Y; Honda Y; Ogura Y
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2664-72. PubMed ID: 11581214
[TBL] [Abstract][Full Text] [Related]
17. Imaging Laser-Induced Choroidal Neovascularization in the Rodent Retina Using Optical Coherence Tomography Angiography.
Park JR; Choi W; Hong HK; Kim Y; Jun Park S; Hwang Y; Kim P; Joon Woo S; Hyung Park K; Oh WY
Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT331-40. PubMed ID: 27409490
[TBL] [Abstract][Full Text] [Related]
18. The antiangiogenic effects of integrin alpha5beta1 inhibitor (ATN-161) in vitro and in vivo.
Wang W; Wang F; Lu F; Xu S; Hu W; Huang J; Gu Q; Sun X
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7213-20. PubMed ID: 21813636
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of TNP-470 on experimental choroidal neovascularization in a rat model.
Ishida K; Yoshimura N; Mandai M; Honda Y
Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1512-9. PubMed ID: 10359334
[TBL] [Abstract][Full Text] [Related]
20. Comparison of long-acting bevacizumab formulations in the treatment of choroidal neovascularization in a rat model.
Pan CK; Durairaj C; Kompella UB; Agwu O; Oliver SC; Quiroz-Mercado H; Mandava N; Olson JL
J Ocul Pharmacol Ther; 2011 Jun; 27(3):219-24. PubMed ID: 21574814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
